Literature DB >> 31766937

Breast Reconstruction for Medicaid Beneficiaries: A Systematic Review of the Current Evidence.

Charalampos Siotos1, Armina Azizi1, Larissa Assam1, Gedge D Rosson1, Stella M Seal2, Craig E Pollack3, Oluseyi Aliu1.   

Abstract

Introduction: Medicaid beneficiaries are a generally disadvantaged population with access to elective specialty services. We sought to better understand utilization of breast reconstruction by Medicaid beneficiaries.
Methods: We systematically searched PubMed, Scopus, Web of Science, and CINAHL databases for studies comparing breast reconstruction rates by insurance type. We extracted the information of interest to qualitatively and quantitatively synthesize the results of the studies.
Results: We identified seven eligible studies. Overall, the rates of breast reconstruction have increased across insurance groups. However, our results show that Medicaid beneficiaries were on average less likely to receive breast reconstruction in comparison to patients with private insurance. Although, Medicaid patients again were more likely to receive breast reconstruction in comparison to Medicare beneficiaries.
Conclusion: There is wide disparity in reconstruction rates by insurance status. However, with continued increase in the adult Medicaid population due to widening eligibility expansion, disparities involving this vulnerable population should be examined for causes and solutions.

Entities:  

Keywords:  Breast cancer; Medicaid; breast reconstruction; insurance type

Year:  2019        PMID: 31766937     DOI: 10.1080/2000656X.2019.1688167

Source DB:  PubMed          Journal:  J Plast Surg Hand Surg        ISSN: 2000-6764


  2 in total

1.  Racial Disparity in Immediate Breast Reconstruction; a Gap That is not Closing.

Authors:  Mahdi Malekpour; Sean Devitt; Joseph DeSantis; Christian Kauffman
Journal:  Plast Surg (Oakv)       Date:  2021-12-06       Impact factor: 0.558

2.  Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?

Authors:  Samilia Obeng-Gyasi; Johnie Rose; Weichuan Dong; Uriel Kim; Siran Koroukian
Journal:  Ann Surg Oncol       Date:  2021-11-27       Impact factor: 4.339

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.